Net Loss Per Ordinary Share Attributable To Nexera Technologies Ltd |
6 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2026 | ||||||||||||||||||||||||||||||||||||||||||||||
| Net Loss Per Ordinary Share Attributable to Nexera Technologies Ltd [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||
| NET LOSS PER ORDINARY SHARE ATTRIBUTABLE TO NEXERA TECHNOLOGIES LTD | NOTE 11 — NET LOSS PER ORDINARY SHARE ATTRIBUTABLE TO NEXERA TECHNOLOGIES LTD
The following table sets forth the computation of basic and diluted net loss per ordinary share:
The following potentially dilutive securities were excluded from the computation of diluted net loss per ordinary share because their effect would have been antidilutive: warrants (including the warrants issued in the Company’s initial public offering, the Additional Warrants, the Series A Warrants, the Series B Warrants, the underwriter warrants and the warrants issued under the Notes SPA and in the June 2026 private placement, and other warrants) and RSUs under the Company’s incentive plans, totaling 695,792 and 15,270 potential ordinary shares as of June 30, 2026 and 2025, respectively, as well as the convertible promissory notes outstanding at each date. |
|||||||||||||||||||||||||||||||||||||||||||||